Form 8-K - Current report:
SEC Accession No. 0001628280-18-006275
Filing Date
2018-05-08
Accepted
2018-05-08 17:06:01
Documents
3
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K Q1 2018 EARNINGS RELEASE q120188k-earningsreleasecl.htm 8-K 35273
2 EXHIBIT 99.1 Q1 2018 EARNINGS RELEASE q12018-ex991earningsreleas.htm EX-99.1 247229
3 cumberlandpharmaimageaa04.jpg GRAPHIC 37721
  Complete submission text file 0001628280-18-006275.txt   335624
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 18815658
SIC: 2834 Pharmaceutical Preparations